| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| August 14, 2014 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 4,000 | $3.20 | 30,311 | |
| June 11, 2014 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 5,000 | $3.20 | 45,081 | |
| June 11, 2014 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 5,000 | $3.20 | 26,331 | |
| June 11, 2014 | CEO | Form 4 | Open market or private purchase of non-derivative or derivative security | 5,000 | $3.20 | 62,521 | |
| August 15, 2014 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 5,000 | $3.12 | 55,081 | |
| August 15, 2014 | CEO | Form 4 | Open market or private purchase of non-derivative or derivative security | 4,000 | $3.12 | 66,521 | |
| August 15, 2014 | CEO | Form 4/A | Open market or private purchase of non-derivative or derivative security | 4,000 | $3.12 | 74,521 | |
| June 13, 2011 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 8,000 | $3.10 | 41,907 | |
| September 16, 2010 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 5,000 | $3.10 | 15,000 | |
| September 22, 2010 | Chief Medical Officer | Form 4 | Open market or private purchase of non-derivative or derivative security | 100 | $3.04 | 28,187 | |
| September 22, 2010 | Chief Medical Officer | Form 4 | Open market or private purchase of non-derivative or derivative security | 1,550 | $3.03 | 28,087 | |
| August 16, 2011 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 5,000 | $3.00 | 46,907 | |
| December 8, 2008 | Chief Financial Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 25,000 | $3.00 | 25,000 | |
| December 8, 2008 | Chief Financial Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 100,000 | $3.00 | 100,000 | |
| December 22, 2009 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 10,000 | $3.00 | 162,562 | |
| February 19, 2010 | Chief Medical Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 7,537 | $2.94 | 26,537 | |
| February 19, 2010 | Chief Medical Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 40,000 | $2.94 | 185,000 | |
| February 19, 2010 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 25,000 | $2.94 | 105,000 | |
| February 19, 2010 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 35,000 | $2.94 | 169,911 | |
| February 19, 2010 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 25,000 | $2.94 | 110,676 | |
| February 19, 2010 | Chief Executive Offier | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 17,412 | $2.94 | 89,328 | |
| February 19, 2010 | Chief Executive Offier | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 85,000 | $2.94 | 698,334 | |
| February 19, 2010 | Interim CAO, Controller | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 2,040 | $2.94 | 2,040 | |
| February 19, 2010 | Interim CAO, Controller | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 5,000 | $2.94 | 15,000 | |
| February 19, 2010 | Interim CAO, Controller | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 10,000 | $2.94 | 25,000 |
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.
